icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Aug 27-29
Digital ILC 2020
Back grey_arrow_rt.gif
 
 
 
Hepatitis B Virus Surface Antigen Inhibition with GSK3228836 (ISIS 505358) in Chronic Hepatitis B Patients on Stable Nucleos(t)ide Analogue Regimen and in Nucleos(t)ide Analogue Na´ve Patients: A Phase 2a, Randomized, Double-blind, Placebo-controlled Study
 
 
  EASL 2020 Aug 27-29 virtual
Reported by Jules Levin
 
Man-Fung Yuen1, Jeong Heo2, Jeong-won Jang3, Jung-Hawn Yoon4, Young-Oh Kweon5, Sung-Jae Park6, C. Frank Bennett7, and T. Jesse Kwoh7 1Queen Mary Hospital, The University of Hong Kong, Hong Kong, 2Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea, 3Seoul St. Mary's Hospital, the Catholic University of Korea, Seoul, Republic of Korea, 4Seoul National University Hospital, Seoul, Republic of Korea, 5Kyungpook National University Hospital, Daegu, Republic of Korea, 6Inje University Busan Paik Hospital, Busan, Republic of Korea, 7Ionis Pharmaceuticals Inc., Carlsbad, CA USA

0828201

0828202

0828203

0828204

0828205

0828206

0828207

0828208